Signification clinique des anticorps antithyroïdiens
| dc.contributor.advisor | L. ESSAADOUNI | |
| dc.contributor.author | Mourad CHAQRAOUI | |
| dc.date.accessioned | 2023-09-19T14:02:46Z | |
| dc.date.accessioned | 2026-01-28T12:22:16Z | |
| dc.date.available | 2023-09-19T14:02:46Z | |
| dc.date.issued | 2017 | |
| dc.description.collaborator | B. ADMOU | |
| dc.description.collaborator | S. CHELLAK | |
| dc.description.collaborator | H. QACIF | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/20805 | |
| dc.language.iso | fr | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Marrakech | fr_FR |
| dc.publisher | Sciences médicales | fr_FR |
| dc.subject.other | Médecine interne | |
| dc.subject.specific | Anticorps antithyroïdiens | |
| dc.subject.specific | Anti-TPO | |
| dc.subject.specific | Anti-TG | |
| dc.subject.specific | Anti-RTSH – Pathologies associées | |
| dc.subject.specific | Signification clinique | |
| dc.title | Signification clinique des anticorps antithyroïdiens | fr_FR |
Files
Original bundle
1 - 1 of 1